Erlotinib/gefitinib/osimertinibDrug resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1729卷 / 1期

关键词：

D O I：

10.1007/s40278-018-54742-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：112 / 112

相关论文

共 50 条

[1] Erlotinib/gefitinib/osimertinibDrug resistance: case report
Reactions Weekly, 2019, 1754 (1) : 150 - 150
[2] Gefitinib/osimertinibDrug resistance: case report
Reactions Weekly, 2019, 1764 (1) : 146 - 146
[3] Erlotinib/osimertinibDrug resistance: case report
Reactions Weekly, 2016, 1598 (1) : 96 - 96
[4] Erlotinib/osimertinibDrug resistance: case report
Reactions Weekly, 2019, 1740 (1) : 142 - 142
[5] Erlotinib/osimertinibDrug resistance: case report
Reactions Weekly, 2021, 1872 (1) : 202 - 202
[6] Erlotinib/gefitinib/osimertinibDrug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2023, 1948 (1) : 199 - 199
[7] Erlotinib/gefitinib/osimertinibDrug resistance, fever and hepatotoxicity with subsequent immunological desensitisation on osimertinib: case report
Reactions Weekly, 2018, 1723 (1) : 139 - 139
[8] Crizotinib/gefitinib/osimertinibDrug resistance and rash: case report
Reactions Weekly, 2019, 1763 (1) : 117 - 117
[9] Gefitinib/osimertinibDrug resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1902 (1) : 219 - 219
[10] Crizotinib/erlotinib/osimertinibDrug resistance, acne and anorexia: case report
Reactions Weekly, 2021, 1852 (1) : 144 - 144

← 1 2 3 4 5 →